new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Ludwig Institute For Cancer Research Ltd
Ludwig Institute For Cancer Research
Ludwig Institute For Cancer Research And Cancer In
  

Ludwig Institute For Cancer Research patents

Recent patent applications related to Ludwig Institute For Cancer Research. Ludwig Institute For Cancer Research is listed as an Agent/Assignee. Note: Ludwig Institute For Cancer Research may have other listings under different names/spellings. We're not affiliated with Ludwig Institute For Cancer Research, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Ludwig Institute For Cancer Research-related inventors




Date Ludwig Institute For Cancer Research patents (updated weekly) - BOOKMARK this page
05/25/17 new patent  Truncated variant of the mammalian target for rapamycin (mtor) protein
04/20/17Devices and methods for prognosis prediction for melanoma cancer
12/15/16Inkt cell modulators and methods of using the same
09/22/16Products and methods for treatment of familial amyotrophic lateral sclerosis
09/08/16Methods and compositions for cdna synthesis and single-cell transcriptome profiling using template switching reaction
08/18/16Methods for modulating expression of c9orf72 antisense transcript
01/07/16In vivo efficacy of ny-eso-1 plus adjuvant
09/24/15Methods for modulating c9orf72 expression
01/29/15Devices and methods for prognosis prediction for melanoma cancer
09/11/14Immunogenic compositions useful in provoking an integrated response to tumor antigens
05/01/14Truncated variant of the mammalian target for rapamycin (mtor) protein
06/20/13Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
10/25/12Analogs of alpha galactosylceramide and uses thereof
08/02/12Method for modulating activity of t lymphocytes
07/19/12Specific binding proteins and uses thereof
05/10/12Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
02/16/12A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
09/22/11Methods for the treatment of cancer
06/23/11Regulation of fatty acid transporters
03/31/11Specific binding proteins and uses thereof
12/31/09Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
12/31/09Methods for stimulating an immune response using bacterial antigen delivery system
10/22/09A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
09/03/09Specific binding proteins and uses thereof
08/27/09Methods and compositions for regulating cell cycle checkpoints
08/27/09Quantification of enzyme activity by mass spectrometry
08/13/09Mage-a3 peptides presented by hla-dr1 molecules
05/07/09Truncated egf receptor
02/19/09Methods and compositions for pdgf-c activation and inhibition
04/20/17Liposomal formulation of nonglycosidic ceramides and uses thereof
03/23/17Anti-pd-1 antibodies and methods of use thereof
01/12/17Anti-metalloprotease antibody for diagnosis and treatment of cancers
12/29/16Method of treating cancer
12/22/16Anti-ctla-4 antibodies and methods of use thereof
12/01/16Anti-ox40 antibodies and methods of use thereof
09/22/16Anti-garp protein and uses thereof
07/07/16Compositions and methods for inhibiting expression of mutant egfr gene
02/18/16Specific binding proteins and uses thereof
10/08/15Iaspp phosphorylation and metastatic potential
05/14/15Tgf-beta1 specific antibodies and methods and uses thereof
12/25/14Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
10/30/14Specific binding proteins and uses thereof
05/22/14Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
02/20/14Liposomal formulation of nonglycosidic ceramides and uses thereof
10/31/13Reversible protein multimers, methods for their production and use
08/29/13Recombinant trypanosoma cruzi cells useful as anti-cancer immune agents
01/31/13Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof
01/10/13Cancer testis antigens as biomarkers in non-small cell lung cancer
11/08/12Seromic analysis of ovarian cancer
11/01/12Ctsp cancer-testis antigens
01/19/12Methods and compositions for diagnosis and treatment of malignant and non-malignant gammopathies
12/22/11Diagnosis and treatment of cancer using cancer-testis antigens
12/01/11Ssx-2 peptides presented by hla class ii molecules
12/01/11Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
11/17/11Quantification of enzyme activity by mass spectrometry using immobilized substrates
06/30/11Trytophan catabolism in cancer treatment and diagnosis
06/16/11Ssx-2 peptides presented by hla class ii molecules
04/21/11Ssx-4 peptides presented by hla class ii molecules
04/07/11Cancer-testis gene silencing agents and uses thereof
12/23/10Methods for diagnosing and treating astrocytomas
09/02/10Methods and compositions for pdgf-c activation and inhibition
07/08/10Human sarcoma-associated antigens
06/10/10Expression of foxp3 by cancer cells
11/05/09Lage-1 tumor associated nucleic acids
09/24/09Breast, gastric and prostate cancer associated antigens and uses therefor
Patent Packs
08/20/09Tumour rejection antigens
07/16/09Ctsp cancer-testis antigens
05/28/09Induction of regulatory t cell-resistant helper cd4+ t cells
04/16/09Ssx-2 peptides presented by hla class ii molecules
04/28/11Colon cancer associated transcript 1 (ccat1) as a cancer marker







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ludwig Institute For Cancer Research in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ludwig Institute For Cancer Research with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';